Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Providence Milwaukie Hospital
mi
from
Milwaukie, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Providence Milwaukie Hospital
mi
from
Milwaukie, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Legacy Good Samaritan Hospital & Comprehensive Cancer Center
mi
from
Portland, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Legacy Good Samaritan Hospital & Comprehensive Cancer Center
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Providence Cancer Center at Providence Portland Medical Center
mi
from
Portland, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Providence Cancer Center at Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Adventist Medical Center
mi
from
Portland, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Adventist Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Columbia River Oncology Program
mi
from
Portland, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Columbia River Oncology Program
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Providence St. Vincent Medical Center
mi
from
Portland, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Providence St. Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Legacy Emanuel Hospital and Health Center & Children's Hospital
mi
from
Portland, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Legacy Emanuel Hospital and Health Center & Children's Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Kaiser Permanente Health Care - Portland
mi
from
Portland, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Kaiser Permanente Health Care - Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Legacy Meridian Park Hospital
mi
from
Tualatin, OR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Legacy Meridian Park Hospital
mi
from
Tualatin, OR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Rosenfeld Cancer Center at Abington Memorial Hospital
mi
from
Abington, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Rosenfeld Cancer Center at Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
mi
from
Allentown, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
mi
from
Allentown, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center
mi
from
Dubois, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center
mi
from
Dubois, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Dale and Frances Hughes Cancer Center at Pocono Medical Center
mi
from
East Stroudsburg, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Dale and Frances Hughes Cancer Center at Pocono Medical Center
mi
from
East Stroudsburg, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Easton Regional Cancer Center at Easton Hospital
mi
from
Easton, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Easton Regional Cancer Center at Easton Hospital
mi
from
Easton, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Ephrata Cancer Center at Ephrata Community Hospital
mi
from
Ephrata, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Ephrata Cancer Center at Ephrata Community Hospital
mi
from
Ephrata, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Regional Cancer Center - Erie
mi
from
Erie, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Regional Cancer Center - Erie
mi
from
Erie, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Saint Vincent Health Center
mi
from
Erie, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Saint Vincent Health Center
mi
from
Erie, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
PinnacleHealth Regional Cancer Center at Polyclinic Hospital
mi
from
Harrisburg, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
PinnacleHealth Regional Cancer Center at Polyclinic Hospital
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Richard G. Laube Cancer Center at ACMH
mi
from
Kittanning, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Richard G. Laube Cancer Center at ACMH
mi
from
Kittanning, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Riddle Memorial Hospital Cancer Center
mi
from
Media, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Riddle Memorial Hospital Cancer Center
mi
from
Media, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Frankford Hospital Cancer Center - Torresdale Campus
mi
from
Philadelphia, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Frankford Hospital Cancer Center - Torresdale Campus
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Allegheny Cancer Center at Allegheny General Hospital
mi
from
Pittsburgh, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Allegheny Cancer Center at Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
UPMC Cancer Centers
mi
from
Pittsburgh, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
UPMC Cancer Centers
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Pottstown Memorial Regional Cancer Center
mi
from
Pottstown, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Pottstown Memorial Regional Cancer Center
mi
from
Pottstown, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
mi
from
Reading, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
mi
from
Reading, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Guthrie Cancer Center at Guthrie Clinic Sayre
mi
from
Sayre, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Guthrie Cancer Center at Guthrie Clinic Sayre
mi
from
Sayre, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Mercy Hospital Cancer Center - Scranton
mi
from
Scranton, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Mercy Hospital Cancer Center - Scranton
mi
from
Scranton, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hematology and Oncology Associates of Northeastern Pennsylvania
mi
from
Scranton, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hematology and Oncology Associates of Northeastern Pennsylvania
mi
from
Scranton, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Mount Nittany Medical Center
mi
from
State College, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center
mi
from
Upland, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center
mi
from
Upland, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
York Cancer Center at Apple Hill Medical Center
mi
from
York, PA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
York Cancer Center at Apple Hill Medical Center
mi
from
York, PA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hematology and Oncology Associates of Rhode Island
mi
from
Cranston, RI
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hematology and Oncology Associates of Rhode Island
mi
from
Cranston, RI
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Kent County Memorial Hospital
mi
from
Warwick, RI
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Kent County Memorial Hospital
mi
from
Warwick, RI
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
AnMed Cancer Center
mi
from
Anderson, SC
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
AnMed Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Greenville
mi
from
Greenville, SC
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Oncology Services of Aberdeen
mi
from
Aberdeen, SD
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Oncology Services of Aberdeen
mi
from
Aberdeen, SD
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
U.T. Medical Center Cancer Institute
mi
from
Knoxville, TN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
U.T. Medical Center Cancer Institute
mi
from
Knoxville, TN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Texas Oncology - Midtown Austin
mi
from
Austin, TX
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Texas Oncology - Midtown Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Texas Oncology, PA at Texas Oncology Cancer Center - Central
mi
from
Austin, TX
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Texas Oncology, PA at Texas Oncology Cancer Center - Central
mi
from
Austin, TX
Click here to add this to my saved trials